Orexigen Up, Then Steeply Down Following Contrave U.S. Rights Agreement
March 15, 2016 at 12:10 PM EDT
Orexigen Therapeutics, Inc. (NASDAQ: OREX) spiked almost 3 percent to $0.81 early Tuesday, but quickly plummeted more than 6 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.